PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY

PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY

Show other versions (1)

Disorders of intermediary metabolism in the glycolysis cycles and fatty acids oxidation play a major role in heart and brain lesions of vascular origin. Features of the free-radical processes in various forms of vascular disease are presented. Differences within the free-radical processes reflecting...

Full description

Bibliographic Details
Main Authors:	S. A. Rumyantseva, R. G. Oganov, V. A. Stupin, E. V. Silina, A. S. Orlova, S. B. Bolevich, V. V. Afanasev, E. N. Kabaeva, S. A. Volik
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	сосудистая коморбидность инфаркт миокарда ишемическая болезнь сердца острый инсульт бета-окисление жирных кислот блокаторы бета-окисления комплексная цитопротекция
Online Access:	http://www.rpcardio.ru/jour/article/view/11

Similar Items

Long-term prognosis of CHD depends on fat tissue levels of lipophylic antioxidants and polyunsaturated fatty acids in patients with acute myocardial infarction
by: I. G. Shiman, et al.
Published: (2004-08-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

BISOPROLOL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CARDIOPULMONARY DISEASES
by: G. N. Gorokchovskaya, et al.
Published: (2016-01-01)

CONTEMPORARY APPROACH TO THE CORRECTION OF COGNITIVE DISORDERS IN PATIENTS WITH VASCULAR COMORBIDITY
by: S. A. Rumianceva, et al.
Published: (2015-09-01)

FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY
by: O. G. Zaylobidinov, et al.
Published: (2016-01-01)

New plant agents with cerebroprotective effect
by: V. N. Burkova, et al.
Published: (2011-10-01)

Lymphatic drainage of the brain in extreme arterial hypertension
by: Ya. M. Pesin, et al.
Published: (2010-08-01)

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Thrombolytic therapy and cardiac free wall rupture in patients with acute myocardial infarction
by: E M Zeltyn-Abramov, et al.
Published: (2009-03-01)

Beta-adrenoblocker therapy in patients with severe chronic heart failure
by: I. I. Sinitsyna, et al.
Published: (2007-02-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

COMPARATIVE EVALUATION OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE
by: S. N. Tolpygina, et al.
Published: (2015-12-01)

Влияние некоторых лекарственных препаратов различных фармакологических групп на вариабельность ритма сердца
Published: (2018-06-01)

DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS (PART I)
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS. PART II
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

ИНТЕРНЕТ-ЭКГ В ДИФФЕРЕНЦИАЛЬНОЙ ДИАГНОСТИКЕ КАРДИАЛГИЙ НА ДОГОСПИТАЛЬНОМ ЭТАПЕ
by: Евгений Владимирович Тимофеев, et al.
Published: (2020-10-01)

Clinical and immunological characteristics of chronic obstructive pulmonary disease with frequent exacerbations associated with obliterating atherosclerosis of lower limb arteries
by: S. N. Kotlyarov, et al.
Published: (2023-10-01)

СЕРДЕЧНО-СОСУДИСТАЯ ЗАБОЛЕВАЕМОСТЬ – ОДНА ИЗ ВАЖНЕЙШИХ ПРОБЛЕМ ЗДРАВООХРАНЕНИЯ
by: Владимир Александрович Глущенко, et al.
Published: (2020-05-01)

THE LIS STUDY (LYUBERTSY STUDY OF MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION). EVALUATION OF THE PHARMACOTHERAPY. PART 1. TREATMENT OF PATIENTS BEFORE MYOCARDIAL INFARCTION AND ITS INFLUENCE ON HOSPITAL MORTALITY RATE
by: S. Y. Marcevich, et al.
Published: (2015-12-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Endothelial dysfunction and hemostasis in acute myocardial infarction before and after Trombovazim therapy
by: Ye. F. Kotovshchikova, et al.
Published: (2011-02-01)

Use of beta-blockers for the treatment of cardiovascular diseases: focus on metoprolol
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

EFFICACY AND SAFETY OF ACCELERATED DIAGNOSTIC PROTOCOL USE IN PATIENTS WITH SUSPECTED ACUTE CORONARY SYNDROME
by: O. V. Baturina, et al.
Published: (2015-09-01)

Шкала оценки тяжести коронарной микрососудистой обструкции (no-reflow) при чрескожных коронарных вмешательствах у пациентов с инфарктом миокарда
by: A.A. Frolov, et al.
Published: (2023-12-01)

Multi-center randomized trial on the impact of “CONFIDENCE” communication program aimed at evaluating therapy adherence of patients with registered myocardial infarction who underwent successful revascularization by stenting or thrombolysis after discharg
by: А. Р. Таркова, et al.
Published: (2017-04-01)

CHANGES IN PREHOSPITAL PHARMACOTHERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN 2005-2014 ACCORDING TO THE LIS REGISTER
by: S. Y. Martsevich, et al.
Published: (2015-09-01)

CAD, myocardial infarction and stroke. Prevalence, associations, impact on outcomes (according to the MERIDIAN-RO study)
by: E. V. Filippov, et al.
Published: (2015-12-01)

THE EFFECT OF INTENSIVE GLYCEMIC CONTROL ON THE FACTORS DETERMINING PREDICTION COMPLICATIONS OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES
by: A. I. Fedotova, et al.
Published: (2015-10-01)

Определение компонентного состава семян чернушки посевной (Nigella sativa)
by: Феськова Е. В., et al.
Published: (2018-01-01)

The effect of depressive disorder on the clinical presentation of coronary artery disease and five-year survival of patients after myocardial infarction
by: T. G. Nonka, et al.
Published: (2022-10-01)

A clinical case of acute coronary syndrome in patients with type 2 diabetes
by: S. V. Kakorin, et al.
Published: (2015-12-01)

THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER)
by: M. L. Ginzburg, et al.
Published: (2015-09-01)

IMMUNO-INFLAMATORY RESPONSES IN ACUTE CORONARY SYNDROME
by: R. G. Oganov, et al.
Published: (2015-12-01)

IMPACT OF ATRIAL FIBRILLATION ON THE NEAR AND LONG-TERM PROGNOSIS OF LIFE AFTER ACUTE MYOCARDIAL INFARCTION. THE DATA OF THE LIS-1 STUDY (LYUBERTSY MORTALITY STUDY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Сравнительный клинико-экономический анализ применения тромболитиков Фортелизин® и Актилизе® у пациентов с острым инфарктом миокарда
Published: (2018-06-01)

Шкала оценки риска феномена no-reflow при чрескожных коронарных вмешательствах у пациентов с острым инфарктом миокарда с подъемом сегмента ST
by: И. Бессонов, et al.
Published: (2020-11-01)

VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT
by: R. G. Oganov
Published: (2015-09-01)

THE LIS STUDY (LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION). EVALUATION OF DRUG THERAPY. PART 2. INFLUENCE OF PREVIOUS DRUG TREATMENT ON LONG-TERM LIFE PROGNOSIS
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

Current clinical and epidemiological portrait of a patient with acute myocardial infarction (by the data of the regional vascular center)
by: E. Yu. Kovalchuk, et al.
Published: (2015-06-01)

Prognostic value of short-term trajectories of left ventricular ejection fraction in patients with first myocardial infarction and percutaneous coronary intervention
by: T. M. Timofeeva, et al.
Published: (2023-01-01)